This report contains market size and forecasts of Point-of-care Cancer Screening in Global, including the following market information:
Global Point-of-care Cancer Screening Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Point-of-care Cancer Screening market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Genetic Screening Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Point-of-care Cancer Screening include Hologic Corporation, Abbott Laboratories, Qiagen N.V., F Hoffmann-La Roche, BD, Quest Diagnostics, OncoHealth Corp, Danaher and NOVIGENIX SA, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Point-of-care Cancer Screening companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Point-of-care Cancer Screening Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Point-of-care Cancer Screening Market Segment Percentages, by Type, 2022 (%)
Genetic Screening
Image Screening
Others
Global Point-of-care Cancer Screening Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Point-of-care Cancer Screening Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Point-of-care Cancer Screening Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Point-of-care Cancer Screening Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Point-of-care Cancer Screening revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Point-of-care Cancer Screening revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hologic Corporation
Abbott Laboratories
Qiagen N.V.
F Hoffmann-La Roche
BD
Quest Diagnostics
OncoHealth Corp
Danaher
NOVIGENIX SA
Quidel Corporation
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Point-of-care Cancer Screening Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Point-of-care Cancer Screening Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Point-of-care Cancer Screening Overall Market Size
2.1 Global Point-of-care Cancer Screening Market Size: 2022 VS 2030
2.2 Global Point-of-care Cancer Screening Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Point-of-care Cancer Screening Players in Global Market
3.2 Top Global Point-of-care Cancer Screening Companies Ranked by Revenue
3.3 Global Point-of-care Cancer Screening Revenue by Companies
3.4 Top 3 and Top 5 Point-of-care Cancer Screening Companies in Global Market, by Revenue in 2022
3.5 Global Companies Point-of-care Cancer Screening Product Type
3.6 Tier 1, Tier 2 and Tier 3 Point-of-care Cancer Screening Players in Global Market
3.6.1 List of Global Tier 1 Point-of-care Cancer Screening Companies
3.6.2 List of Global Tier 2 and Tier 3 Point-of-care Cancer Screening Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Point-of-care Cancer Screening Market Size Markets, 2022 & 2030
4.1.2 Genetic Screening
4.1.3 Image Screening
4.1.4 Others
4.2 By Type - Global Point-of-care Cancer Screening Revenue & Forecasts
4.2.1 By Type - Global Point-of-care Cancer Screening Revenue, 2018-2023
4.2.2 By Type - Global Point-of-care Cancer Screening Revenue, 2023-2030
4.2.3 By Type - Global Point-of-care Cancer Screening Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Point-of-care Cancer Screening Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Point-of-care Cancer Screening Revenue & Forecasts
5.2.1 By Application - Global Point-of-care Cancer Screening Revenue, 2018-2023
5.2.2 By Application - Global Point-of-care Cancer Screening Revenue, 2023-2030
5.2.3 By Application - Global Point-of-care Cancer Screening Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Point-of-care Cancer Screening Market Size, 2022 & 2030
6.2 By Region - Global Point-of-care Cancer Screening Revenue & Forecasts
6.2.1 By Region - Global Point-of-care Cancer Screening Revenue, 2018-2023
6.2.2 By Region - Global Point-of-care Cancer Screening Revenue, 2023-2030
6.2.3 By Region - Global Point-of-care Cancer Screening Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Point-of-care Cancer Screening Revenue, 2018-2030
6.3.2 US Point-of-care Cancer Screening Market Size, 2018-2030
6.3.3 Canada Point-of-care Cancer Screening Market Size, 2018-2030
6.3.4 Mexico Point-of-care Cancer Screening Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Point-of-care Cancer Screening Revenue, 2018-2030
6.4.2 Germany Point-of-care Cancer Screening Market Size, 2018-2030
6.4.3 France Point-of-care Cancer Screening Market Size, 2018-2030
6.4.4 U.K. Point-of-care Cancer Screening Market Size, 2018-2030
6.4.5 Italy Point-of-care Cancer Screening Market Size, 2018-2030
6.4.6 Russia Point-of-care Cancer Screening Market Size, 2018-2030
6.4.7 Nordic Countries Point-of-care Cancer Screening Market Size, 2018-2030
6.4.8 Benelux Point-of-care Cancer Screening Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Point-of-care Cancer Screening Revenue, 2018-2030
6.5.2 China Point-of-care Cancer Screening Market Size, 2018-2030
6.5.3 Japan Point-of-care Cancer Screening Market Size, 2018-2030
6.5.4 South Korea Point-of-care Cancer Screening Market Size, 2018-2030
6.5.5 Southeast Asia Point-of-care Cancer Screening Market Size, 2018-2030
6.5.6 India Point-of-care Cancer Screening Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Point-of-care Cancer Screening Revenue, 2018-2030
6.6.2 Brazil Point-of-care Cancer Screening Market Size, 2018-2030
6.6.3 Argentina Point-of-care Cancer Screening Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Point-of-care Cancer Screening Revenue, 2018-2030
6.7.2 Turkey Point-of-care Cancer Screening Market Size, 2018-2030
6.7.3 Israel Point-of-care Cancer Screening Market Size, 2018-2030
6.7.4 Saudi Arabia Point-of-care Cancer Screening Market Size, 2018-2030
6.7.5 UAE Point-of-care Cancer Screening Market Size, 2018-2030
7 Players Profiles
7.1 Hologic Corporation
7.1.1 Hologic Corporation Corporate Summary
7.1.2 Hologic Corporation Business Overview
7.1.3 Hologic Corporation Point-of-care Cancer Screening Major Product Offerings
7.1.4 Hologic Corporation Point-of-care Cancer Screening Revenue in Global Market (2018-2023)
7.1.5 Hologic Corporation Key News
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Corporate Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Point-of-care Cancer Screening Major Product Offerings
7.2.4 Abbott Laboratories Point-of-care Cancer Screening Revenue in Global Market (2018-2023)
7.2.5 Abbott Laboratories Key News
7.3 Qiagen N.V.
7.3.1 Qiagen N.V. Corporate Summary
7.3.2 Qiagen N.V. Business Overview
7.3.3 Qiagen N.V. Point-of-care Cancer Screening Major Product Offerings
7.3.4 Qiagen N.V. Point-of-care Cancer Screening Revenue in Global Market (2018-2023)
7.3.5 Qiagen N.V. Key News
7.4 F Hoffmann-La Roche
7.4.1 F Hoffmann-La Roche Corporate Summary
7.4.2 F Hoffmann-La Roche Business Overview
7.4.3 F Hoffmann-La Roche Point-of-care Cancer Screening Major Product Offerings
7.4.4 F Hoffmann-La Roche Point-of-care Cancer Screening Revenue in Global Market (2018-2023)
7.4.5 F Hoffmann-La Roche Key News
7.5 BD
7.5.1 BD Corporate Summary
7.5.2 BD Business Overview
7.5.3 BD Point-of-care Cancer Screening Major Product Offerings
7.5.4 BD Point-of-care Cancer Screening Revenue in Global Market (2018-2023)
7.5.5 BD Key News
7.6 Quest Diagnostics
7.6.1 Quest Diagnostics Corporate Summary
7.6.2 Quest Diagnostics Business Overview
7.6.3 Quest Diagnostics Point-of-care Cancer Screening Major Product Offerings
7.6.4 Quest Diagnostics Point-of-care Cancer Screening Revenue in Global Market (2018-2023)
7.6.5 Quest Diagnostics Key News
7.7 OncoHealth Corp
7.7.1 OncoHealth Corp Corporate Summary
7.7.2 OncoHealth Corp Business Overview
7.7.3 OncoHealth Corp Point-of-care Cancer Screening Major Product Offerings
7.7.4 OncoHealth Corp Point-of-care Cancer Screening Revenue in Global Market (2018-2023)
7.7.5 OncoHealth Corp Key News
7.8 Danaher
7.8.1 Danaher Corporate Summary
7.8.2 Danaher Business Overview
7.8.3 Danaher Point-of-care Cancer Screening Major Product Offerings
7.8.4 Danaher Point-of-care Cancer Screening Revenue in Global Market (2018-2023)
7.8.5 Danaher Key News
7.9 NOVIGENIX SA
7.9.1 NOVIGENIX SA Corporate Summary
7.9.2 NOVIGENIX SA Business Overview
7.9.3 NOVIGENIX SA Point-of-care Cancer Screening Major Product Offerings
7.9.4 NOVIGENIX SA Point-of-care Cancer Screening Revenue in Global Market (2018-2023)
7.9.5 NOVIGENIX SA Key News
7.10 Quidel Corporation
7.10.1 Quidel Corporation Corporate Summary
7.10.2 Quidel Corporation Business Overview
7.10.3 Quidel Corporation Point-of-care Cancer Screening Major Product Offerings
7.10.4 Quidel Corporation Point-of-care Cancer Screening Revenue in Global Market (2018-2023)
7.10.5 Quidel Corporation Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Point-of-care Cancer Screening Market Opportunities & Trends in Global Market
Table 2. Point-of-care Cancer Screening Market Drivers in Global Market
Table 3. Point-of-care Cancer Screening Market Restraints in Global Market
Table 4. Key Players of Point-of-care Cancer Screening in Global Market
Table 5. Top Point-of-care Cancer Screening Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Point-of-care Cancer Screening Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Point-of-care Cancer Screening Revenue Share by Companies, 2018-2023
Table 8. Global Companies Point-of-care Cancer Screening Product Type
Table 9. List of Global Tier 1 Point-of-care Cancer Screening Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Point-of-care Cancer Screening Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Point-of-care Cancer Screening Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Point-of-care Cancer Screening Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Point-of-care Cancer Screening Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Point-of-care Cancer Screening Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Point-of-care Cancer Screening Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Point-of-care Cancer Screening Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Point-of-care Cancer Screening Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Point-of-care Cancer Screening Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Point-of-care Cancer Screening Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Point-of-care Cancer Screening Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Point-of-care Cancer Screening Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Point-of-care Cancer Screening Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Point-of-care Cancer Screening Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Point-of-care Cancer Screening Revenue, (US$, Mn), 2023-2030
Table 30. Hologic Corporation Corporate Summary
Table 31. Hologic Corporation Point-of-care Cancer Screening Product Offerings
Table 32. Hologic Corporation Point-of-care Cancer Screening Revenue (US$, Mn), (2018-2023)
Table 33. Abbott Laboratories Corporate Summary
Table 34. Abbott Laboratories Point-of-care Cancer Screening Product Offerings
Table 35. Abbott Laboratories Point-of-care Cancer Screening Revenue (US$, Mn), (2018-2023)
Table 36. Qiagen N.V. Corporate Summary
Table 37. Qiagen N.V. Point-of-care Cancer Screening Product Offerings
Table 38. Qiagen N.V. Point-of-care Cancer Screening Revenue (US$, Mn), (2018-2023)
Table 39. F Hoffmann-La Roche Corporate Summary
Table 40. F Hoffmann-La Roche Point-of-care Cancer Screening Product Offerings
Table 41. F Hoffmann-La Roche Point-of-care Cancer Screening Revenue (US$, Mn), (2018-2023)
Table 42. BD Corporate Summary
Table 43. BD Point-of-care Cancer Screening Product Offerings
Table 44. BD Point-of-care Cancer Screening Revenue (US$, Mn), (2018-2023)
Table 45. Quest Diagnostics Corporate Summary
Table 46. Quest Diagnostics Point-of-care Cancer Screening Product Offerings
Table 47. Quest Diagnostics Point-of-care Cancer Screening Revenue (US$, Mn), (2018-2023)
Table 48. OncoHealth Corp Corporate Summary
Table 49. OncoHealth Corp Point-of-care Cancer Screening Product Offerings
Table 50. OncoHealth Corp Point-of-care Cancer Screening Revenue (US$, Mn), (2018-2023)
Table 51. Danaher Corporate Summary
Table 52. Danaher Point-of-care Cancer Screening Product Offerings
Table 53. Danaher Point-of-care Cancer Screening Revenue (US$, Mn), (2018-2023)
Table 54. NOVIGENIX SA Corporate Summary
Table 55. NOVIGENIX SA Point-of-care Cancer Screening Product Offerings
Table 56. NOVIGENIX SA Point-of-care Cancer Screening Revenue (US$, Mn), (2018-2023)
Table 57. Quidel Corporation Corporate Summary
Table 58. Quidel Corporation Point-of-care Cancer Screening Product Offerings
Table 59. Quidel Corporation Point-of-care Cancer Screening Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Point-of-care Cancer Screening Segment by Type in 2022
Figure 2. Point-of-care Cancer Screening Segment by Application in 2022
Figure 3. Global Point-of-care Cancer Screening Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Point-of-care Cancer Screening Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Point-of-care Cancer Screening Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Point-of-care Cancer Screening Revenue in 2022
Figure 8. By Type - Global Point-of-care Cancer Screening Revenue Market Share, 2018-2030
Figure 9. By Application - Global Point-of-care Cancer Screening Revenue Market Share, 2018-2030
Figure 10. By Region - Global Point-of-care Cancer Screening Revenue Market Share, 2018-2030
Figure 11. By Country - North America Point-of-care Cancer Screening Revenue Market Share, 2018-2030
Figure 12. US Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Point-of-care Cancer Screening Revenue Market Share, 2018-2030
Figure 16. Germany Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2030
Figure 17. France Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Point-of-care Cancer Screening Revenue Market Share, 2018-2030
Figure 24. China Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2030
Figure 28. India Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Point-of-care Cancer Screening Revenue Market Share, 2018-2030
Figure 30. Brazil Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Point-of-care Cancer Screening Revenue Market Share, 2018-2030
Figure 33. Turkey Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Point-of-care Cancer Screening Revenue, (US$, Mn), 2018-2030
Figure 37. Hologic Corporation Point-of-care Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Abbott Laboratories Point-of-care Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Qiagen N.V. Point-of-care Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. F Hoffmann-La Roche Point-of-care Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. BD Point-of-care Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Quest Diagnostics Point-of-care Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. OncoHealth Corp Point-of-care Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Danaher Point-of-care Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. NOVIGENIX SA Point-of-care Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Quidel Corporation Point-of-care Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
